Effects of Transcutaneous Application of Carbon Dioxide on diabetic muscle atrophy

Introduction Diabetes results in muscle atrophy, also called diabetic myopathy. Both the increase in muscle proteolysis and the decrease in muscle protein synthesis contribute to diabetic muscle atrophy. Transcutaneous application of carbon dioxide (CO2) has been used for cardiac disease and skin pr...

Full description

Saved in:
Bibliographic Details
Published in:The FASEB journal Vol. 32; no. S1; p. lb395
Main Authors: Kondo, Hiroyo, Tani, Tomomi, Naito, Kana, Niimi, Yurina, Nakane, Moemi, Sugiyama, Yui, Okayasu, Kanako, Takemoto, Hatsumi, Matsumoto, Tomohiro, Takuwa, Miho, Hirabayashi, Takumi, Ikeji, Takuya, Ono, Kohei, Fujino, Hidemi
Format: Journal Article
Language:English
Published: The Federation of American Societies for Experimental Biology 01-04-2018
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction Diabetes results in muscle atrophy, also called diabetic myopathy. Both the increase in muscle proteolysis and the decrease in muscle protein synthesis contribute to diabetic muscle atrophy. Transcutaneous application of carbon dioxide (CO2) has been used for cardiac disease and skin problems for a long time. In addition, it has been reported the CO2 treatment leads to an increase of muscle mass in normal rats. Therefore, the transcutaneous application of CO2 would have a therapeutic potential for diabetic muscle atrophy. The aim of the present study was to investigate the effects of transcutaneous application of CO2 on diabetic muscle atrophy. Methods Male Goto‐kakizaki rats were divided into control and CO2 treatment groups. The hair on the lower limbs was shaved and the hydrogel was applied. The CO2 adaptor was attached to the limbs and sealed, and CO2 was administered into the adaptor for 30 min. This treatment was performed everyday for 8 weeks. Results The body weight, epididymal and retroperitoneal fat were lower in the CO2 treatment group than in the control. In addition, the level of fasting blood glucose in the CO2 treatment group was significantly decreased compared with the control. Furthermore, the muscle masses of lower limbs in the CO2 treatment group were higher than those in the control. Conclution These results indicate that the transcutaneous CO2 treatment may have a therapeutic potential for diabetic muscle atrophy. Support or Funding Information Supported by Grants‐in‐Aid for Science Research from the Japanese MEXT. This is from the Experimental Biology 2018 Meeting. There is no full text article associated with this published in The FASEB Journal.
ISSN:0892-6638
1530-6860
DOI:10.1096/fasebj.2018.32.1_supplement.lb395